Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2025 Should Xenotransplantation Surgeries Be Authorized Under the Food and Drug Administration’s Expanded Access Pathway? Christopher Bobier, PhD, Daniel J. Hurst, PhD, and Daniel Rodger, MA This article examines use of the US Food and Drug Administration’s expanded access pathway to permit cardiac xenotransplants. AMA J Ethics. 2025;27(3):E197-200. doi: 10.1001/amajethics.2025.197.
Policy Forum Mar 2025 Should Xenotransplantation Surgeries Be Authorized Under the Food and Drug Administration’s Expanded Access Pathway? Christopher Bobier, PhD, Daniel J. Hurst, PhD, and Daniel Rodger, MA This article examines use of the US Food and Drug Administration’s expanded access pathway to permit cardiac xenotransplants. AMA J Ethics. 2025;27(3):E197-200. doi: 10.1001/amajethics.2025.197.
